Specific instances of nanotechnology application in prostate cancer screening include the use of gold nanoparticle-based assays to improve the detection sensitivity of PSA levels and the development of nanoparticle-enhanced imaging techniques that provide superior specificity in identifying malignant prostate tissue (32, 33). Here, KLK3 is linked to prostate carcinoma.